poster

Reliable, Scalable Assessment in Routine Practice-Implementing Rapid Clozapine Blood Levels in the Real World

The project's objective was to implement rapid clozapine blood level testing at a large academic medical center. Upon implementation, the time to receive test results improved from 87.4 h...

10/26/2023

Safety and Efficacy of KarXT in Schizophrenia in the Randomized, Double-Blind, Placebo-Controlled, Phase 3 EMERGENT-3 Trial

In the EMERGENT-3 phase 3 trial, KarXT, a combination of xanomeline (M1/M4 muscarinic receptor agonist) and trospium chloride (muscarinic receptor antagonist), demonstrated significant ef...

10/26/2023

Real-World Antipsychotic and Vesicular Monoamine Transporter Type 2 Inhibitor Treatment Patterns in Patients Newly Diagnosed With Tardive Dyskinesia

Antipsychotic (AP) and vesicular monoamine transporter type 2 inhibitor (VMAT2i) treatment patterns post-tardive dyskinesia (TD) diagnosis are unclear. Deutetrabenazine (DTBZ) is a VMAT2i...

10/26/2023

Real-World Antipsychotic Treatment Modification With and Without Deutetrabenazine in Patients Newly Diagnosed With Tardive Dyskinesia

Tardive dyskinesia (TD) management includes antipsychotic (AP) dose modification/discontinuation, often leaving underlying psychiatric conditions undertreated. Deutetrabenazine (DTBZ) is ...

10/26/2023

Real-World Effectiveness of Deutetrabenazine When Initiated Using a 4-Week Patient Titration Kit: Interim Results of the START Study

START is an ongoing, noninterventional, prospective, single-arm, 2-cohort (tardive dyskinesia [TD] and Huntington disease) study evaluating the effectiveness of deutetrabenazine initiated...

10/26/2023

Real-World Observational Study of Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care

The Pathway Platform supports MBC for patients with MDD by integrating a patient-facing app with EHR. This real-world Pathway Platform implementation study in primary care demonstrated si...

10/26/2023

Real-World Safety Profile of Esketamine Nasal Spray During the First 12 Treatment Sessions: An Analysis at 46 Months After Approval in the United States

This research examined real-world safety data for esketamine nasal spray (ESK) for the first 46 months after product approval, with a focus on adverse events (AEs) of interest (i.e., seda...

10/26/2023

Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-world Data for the 1-Month and 3-Month Formulations

Compare efficacy of the three paliperidone palmitate (PP) long-acting injectable formulations for relapse prevention in schizophrenia: Relapse in schizophrenia has pronounced consequences...

10/26/2023

Prevalence of Abnormal CYP2D6 Phenotypes in those with Treatment Resistant Depression

In a retrospective analysis of 356 patients, abnormal CYP2D6 variants were significantly more prevalent in those with treatment-resistant depression than those with other types of depress...

10/26/2023

Prevalence of concomitant medications among patients with schizophrenia prescribed atypical antipsychotics

The prevalence of concomitant medication use in patients with schizophrenia has not been well established. This study aimed to bridge this gap by evaluating the annual prevalence of conco...

10/26/2023

Tracks

MDD Insights

Schizophrenia Insights

Major Depressive Disorder

General Psychiatry

ADHD

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.

December 9 ⁠–⁠ December 11

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

May 28 ⁠–⁠ May 31

See Full Calendar

poster

Tracks

About

Specialties

Events

Year Round Education

HMP Global Products